BioSpace

Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events

Patients had adverse events after receiving a Fresenius Kabi medicine that experienced manufacturing deviations.

作者 BioSpace

1 分钟阅读
Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events
Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察